HAEMOPHILIA A
Clinical trials for HAEMOPHILIA A explained in plain language.
Never miss a new study
Get alerted when new HAEMOPHILIA A trials appear
Sign up with your email to follow new studies for HAEMOPHILIA A, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for haemophilia a patients: immune therapy aims to neutralize treatment-blocking antibodies
Disease control Recruiting nowThis study tests a treatment called immune tolerance induction (ITI) in 300 people with haemophilia A who have developed inhibitors—antibodies that block standard clotting factor therapy. The goal is to eliminate these inhibitors using high doses of individualized clotting factor…
Matched conditions: HAEMOPHILIA A
Sponsor: Haemophilia Centre Rhine Main • Aim: Disease control
Last updated May 26, 2026 11:29 UTC
-
New hope for hemophilia: study tests drug to prevent bleeding in untreated patients
Disease control Recruiting nowThis study is testing a new medicine called SCT800 to prevent bleeding episodes in people with severe hemophilia A who have never received treatment before. The goal is to see if regular infusions of SCT800 can safely reduce the number of bleeds. About 36 male participants will r…
Matched conditions: HAEMOPHILIA A
Phase: PHASE3 • Sponsor: Sinocelltech Ltd. • Aim: Disease control
Last updated May 26, 2026 11:26 UTC
-
New pill for hemophilia a enters human safety testing
Disease control Recruiting nowThis study tests an experimental oral medicine called Inno8 in 30 adults with hemophilia A, a bleeding disorder. The main goal is to see if different doses are safe and how the body handles the medicine. Participants will take multiple doses by mouth over about 11 weeks, and rese…
Matched conditions: HAEMOPHILIA A
Phase: PHASE1 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated May 22, 2026 13:50 UTC
-
New study tracks Real-World use of clotting factor in hemophilia a patients
Disease control Recruiting nowThis study observes how well Octapharma's FVIII concentrates (Nuwiq, Octanate, Wilate) work in real life for people with severe hemophilia A who have had little or no prior treatment. Researchers will track bleeding events and side effects over time. The goal is to understand the…
Matched conditions: HAEMOPHILIA A
Sponsor: Octapharma • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
New study tracks Real-World use of clotting drug in iraqi hemophilia patients
Knowledge-focused Recruiting nowThis study observes how the clotting medicine turoctocog alfa is used in daily practice for Iraqi patients with hemophilia A. Researchers will review medical records of 900 male patients to track bleeding rates and treatment patterns. The study does not change how patients are tr…
Matched conditions: HAEMOPHILIA A
Sponsor: Novo Nordisk A/S • Aim: Knowledge-focused
Last updated May 20, 2026 11:54 UTC
-
Timing your meals could change how this hemophilia drug works
Knowledge-focused Recruiting nowThis study tests a new medicine called Inno8 in 80 healthy men aged 18-45. The goal is to see how eating and drinking before and after taking the drug affects how well it is absorbed. Participants will fast overnight, take the medicine, and then fast again for different lengths o…
Matched conditions: HAEMOPHILIA A
Phase: PHASE1 • Sponsor: Novo Nordisk A/S • Aim: Knowledge-focused
Last updated May 20, 2026 11:53 UTC